8GWF image
Deposition Date 2022-09-17
Release Date 2023-01-11
Last Version Date 2025-07-02
Entry Detail
PDB ID:
8GWF
Keywords:
Title:
A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analogue inhibitors
Biological Source:
Method Details:
Experimental Method:
Resolution:
3.39 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:RNA-directed RNA polymerase
Gene (Uniprot):rep
Chain IDs:A
Chain Length:932
Number of Molecules:1
Biological Source:Severe acute respiratory syndrome coronavirus 2
Polymer Type:polypeptide(L)
Molecule:Non-structural protein 8
Gene (Uniprot):rep
Chain IDs:B, D
Chain Length:198
Number of Molecules:2
Biological Source:Severe acute respiratory syndrome coronavirus 2
Polymer Type:polypeptide(L)
Molecule:Non-structural protein 7
Chain IDs:C
Chain Length:83
Number of Molecules:1
Biological Source:Severe acute respiratory syndrome coronavirus 2
Polymer Type:polypeptide(L)
Molecule:Helicase
Gene (Uniprot):rep
Chain IDs:G (auth: F), H (auth: E)
Chain Length:601
Number of Molecules:2
Biological Source:Severe acute respiratory syndrome coronavirus 2
Polymer Type:polypeptide(L)
Molecule:Non-structural protein 9
Gene (Uniprot):rep
Chain IDs:I (auth: G)
Chain Length:117
Number of Molecules:1
Biological Source:Severe acute respiratory syndrome coronavirus 2
Polymer Type:polyribonucleotide
Molecule:primer
Chain IDs:E (auth: I)
Chain Length:25
Number of Molecules:1
Biological Source:Severe acute respiratory syndrome coronavirus 2
Polymer Type:polyribonucleotide
Molecule:template
Chain IDs:F (auth: J)
Chain Length:33
Number of Molecules:1
Biological Source:Severe acute respiratory syndrome coronavirus 2
Primary Citation
A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analog inhibitors.
Cell 185 4347 4360.e17 (2022)
PMID: 36335936 DOI: 10.1016/j.cell.2022.09.037

Abstact

Decoration of cap on viral RNA plays essential roles in SARS-CoV-2 proliferation. Here, we report a mechanism for SARS-CoV-2 RNA capping and document structural details at atomic resolution. The NiRAN domain in polymerase catalyzes the covalent link of RNA 5' end to the first residue of nsp9 (termed as RNAylation), thus being an intermediate to form cap core (GpppA) with GTP catalyzed again by NiRAN. We also reveal that triphosphorylated nucleotide analog inhibitors can be bonded to nsp9 and fit into a previously unknown "Nuc-pocket" in NiRAN, thus inhibiting nsp9 RNAylation and formation of GpppA. S-loop (residues 50-KTN-52) in NiRAN presents a remarkable conformational shift observed in RTC bound with sofosbuvir monophosphate, reasoning an "induce-and-lock" mechanism to design inhibitors. These findings not only improve the understanding of SARS-CoV-2 RNA capping and the mode of action of NAIs but also provide a strategy to design antiviral drugs.

Legend

Protein

Chemical

Disease

Primary Citation of related structures